
At least five people have been killed in a bomb explosion in a packed mosque in Nigeria's north-eastern Borno state, a police spokesman has said.
Nahum Daso told local media another 35 people were injured in the blast in the Gamboru market of Maiduguri, the state capital, during evening prayers.
Unverified footage on social media appears to show the aftermath of the explosion, with people stood in a market area with dust particles in the air.
No group has admitted carrying out the attack, but militants have previously targeted mosques and crowded places in the area with suicide attacks and improvised explosive devices (IED).
Maiduguri has been central to an insurgency by the militant Islamist group Boko Haram and its offshoot Islamic State West Africa Province.
Military operations by Boko Haram to create an Islamic caliphate in Borno state began in 2009.
Security measures against the group have failed to prevent sporadic attacks against civilians in north-east Nigeria.
latest_posts
- 1
UN experts urge investigation into Israel’s killing of Lebanese journalists - 2
ACA subsidies latest: Making sense of what's happening with health care after Republicans revolt, forcing a vote on funding extension - 3
Forget 'Outer Banks.' These Gen Z-ers just want to watch 'M*A*S*H*' and 'Gilmore Girls.' - 4
The World's Dazzling Regular Miracles - 5
Council removes proposal to rename park named after former president of Israel
Foods with healthy-sounding buzzwords could be hiding added sugar in plain sight
Iran begins cloud seeding to induce rain amid historic drought
Figure out how to Put resources into Lab Precious stones: A Novice's Aide
Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
Video of clashes over purported conscription orders misrepresented as anti-war protest in Israel
‘It’s Israeli policy’: Report reveals abuse of Palestinians in prisons
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
Vote in favor of your Favored kind of craftsmanship
Roche breast cancer pill cuts risk of disease recurrence by 30% in trial













